Journal of Clinical Endocrinology & Metabolism, Vol 77, 173-177, Copyright © 1993 by Endocrine Society

ARTICLES

The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome

MT Gomez, MA Magiakou, G Mastorakos and GP Chrousos
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Patients cured from endogenous Cushing syndrome usually develop postoperative adrenal suppression in the year ensuing surgery. To define whether the pituitary corticotroph is the rate limiting step in the postoperative recovery of this secondary/tertiary form of adrenal insufficiency, we examined surgically cured patients with Cushing syndrome 10 days, 3 months, and 6-12 months after surgery, by administering ovine CRH (oCRH) iv at the dose of 1 microgram/kg.h over 24 h. The pituitary corticotroph of these patients responded vigorously to oCRH, with ACTH concentrations reaching above the normal range at all three times of testing. Parallel measurements of cortisol in nonadrenalectomized patients demonstrated subnormal adrenal responsiveness at 10 days and 3 months and normalization at 6-12 months after surgery. The circadian rhythm of ACTH was maintained postoperatively at 10 days and 6-12 months, and the circadian rhythm of cortisol was also present at 6-12 months after surgery, in spite of the constant infusions of pharmacological doses of oCRH, suggesting that factors other than CRH secretion regulate this rhythm. We conclude that the corticotroph is not the rate limiting step in the recovery of the hypothalamic-pituitary-adrenal axis from glucocorticoid-induced adrenal suppression, and that the locus of the defect resides in the hypothalamic CRH neuron and/or its higher regulatory inputs.

This article has been cited by other articles:

				M. Bloch, D. R. Rubinow, P. J. Schmidt, A. Lotsikas, G. P. Chrousos, and G. Cizza Cortisol Response to Ovine Corticotropin-Releasing Hormone in a Model of Pregnancy and Parturition in Euthymic Women with and without a History of Postpartum Depression J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 695 - 699. [Abstract] [Full Text] [PDF]

				P. U. Freda and S. L. Wardlaw Diagnosis and Treatment of Pituitary Tumors J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3859 - 3866. [Full Text]

				S. P. Malkoski and R. I. Dorin Composite Glucocorticoid Regulation at a Functionally Defined Negative Glucocorticoid Response Element of the Human Corticotropin-Releasing Hormone Gene Mol. Endocrinol., October 1, 1999; 13(10): 1629 - 1644. [Abstract] [Full Text]

				G. P. Chrousos Editorial: Ultradian, Circadian, and Stress-Related Hypothalamic-Pituitary-Adrenal Axis Activity--A Dynamic Digital-to-Analog Modulation Endocrinology, February 1, 1998; 139(2): 437 - 440. [Full Text] [PDF]

				D. Michelson, E. Galliven, L. Hill, M. Demitrack, G. Chrousos, and P. Gold Chronic Imipramine Is Associated with Diminished Hypothalamic-Pituitary-Adrenal Axis Responsivity in Healthy Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2601 - 2606. [Abstract] [Full Text] [PDF]

				M. A. Magiakou, G. Mastorakos, K. Zachman, and G. P. Chrousos Blood Pressure in Children and Adolescents with Cushing's Syndrome before and after Surgical Cure J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1734 - 1738. [Abstract] [Full Text] [PDF]

				L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919. [Abstract] [Full Text] [PDF]

				G. Cizza, P. W. Gold, and G. P. Chrousos High-Dose Transdermal Estrogen, Corticotropin-Releasing Hormone, and Postnatal Depression J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 703 - 704. [Full Text] [PDF]